| 000 | 02020cam a2200337 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223031601.0 | ||
| 008 | 161023s2016 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.12.08.M.Sc.2016.Al.C | ||
| 100 | 0 | _aAli Abdelaziz Ali Aglan | |
| 245 | 1 | 0 |
_aChromatographic and spectrophotometric determination of Antihistaminic; antihypertensive and antiepatitis C model drugs / _cAli Abdelaziz Ali Aglan ; Supervised Fakiha Mohamed Eltaib Heakal , Tamer Awad Elsayed Ali |
| 246 | 1 | 5 | _a التقدير الكروماتوجرافى والطيفى لنماذج ادوية ضد الحساسية وضد الضغط المرتفع وضد الالتهاب الكبدى سى |
| 260 |
_aCairo : _bAli Abdelaziz Ali Aglan , _c2016 |
||
| 300 |
_a196 P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Science - Department of Analytical Chemistry | ||
| 520 | _aThe Present work has been carried out to investigate: A- Development and validation of a rapid RP-HPLC method for determination of paracetamol with fexofenadine hydrochloride in pure drugs and in binary pharmaceutical dosage forms. B- RP-HPLC stability-indicating method for estimation of irbesartan and hydrochlorothiazide in bulk and pharmaceutical dosage form. C- Validated stability-indicating RP-HPLC-method for the determination of Sofosbuvir in pure drug and in tablet dosage form. D- Stability-indicating spectrophotometric method for the determination of sofosbuvir in bulk and pharmaceyitical formulation | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _afexofenadine hydrochloride | |
| 653 | 4 | _aIrbesartan | |
| 653 | 4 | _aParacetamol | |
| 700 | 0 |
_aFakiha Mohamed Eltaib Heakal , _eSupervisor |
|
| 700 | 0 |
_aTamer Awad Elsayed Ali , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c58251 _d58251 |
||